Table of Contents Table of Contents
Previous Page  112 / 114 Next Page
Information
Show Menu
Previous Page 112 / 114 Next Page
Page Background

108

NCCN Guidelines for Patients

®

Breast Cancer - Early-Stage

(STAGES I AND II)

, Version 1.2016

Index

2

nd

opinion

94

21-gene RT-PCR test

45

biopsy

12, 17, 20–21, 26, 32, 34–36, 82–83

blood tests

17, 20, 26, 70, 82

breast-conserving therapy

30, 32, 38, 59, 77, 84–85, 94

breast reconstruction

12, 28, 31–32, 36–38, 91, 94

cancer stage

10, 34, 90

chemotherapy

12, 14, 32, 34, 40–54, 56, 66, 70, 85

clinical trial

10, 14, 58, 91

endocrine therapy

12–14, 32, 58–59, 66–74, 78, 80, 85

fertility

24

HER2

12, 14, 17, 22–23, 26, 32, 40–54, 56, 66, 83, 85

hereditary breast cancers

16–17, 24, 26, 82–83

hormone receptor

17, 22–23, 32, 44–45, 58–59, 66,

68–69, 74

imaging tests

18–21, 26, 32, 34–35, 77, 82–83, 94

immunohistochemistry

22

lumpectomy

12, 30–32, 36, 38, 58–59, 64, 77

lymph node

6–8, 10–12, 17–18, 21, 26, 28, 32, 34–35, 38,

44–47, 56, 58–61, 64, 68–69, 74, 78, 83–86

mammogram

17–19, 32, 77, 80

mastectomy

12, 30–32, 34, 36–38, 60–61, 64, 77, 84–85,

94

medical history

16–17, 26, 76–77, 80, 82–83

NCCN Member Institutions

107

NCCN Panel Members

106

nipple replacement

37

pathology report

20, 90, 94

physical exam

17, 20–21, 32, 34–35, 76–77, 80, 82–83

radiation therapy

12–14, 30, 38, 56–64, 66, 70, 77, 84–86

sentinel lymph node dissection

12, 38

supportive care

10

triple-negative breast cancer

44

Index